Coronavirus Update: BARDA Funds AstraZeneca Antibody Research
Executive Summary
Also: remdesivir filed in the EU.
You may also be interested in...
Stockwatch: Antibodies And Coronavirus – It’s Complicated
The use of antibodies in disease prevention and treatment is now ingrained in modern medicine but as antiviral agents their record is at best patchy and the reliance on them to treat or prevent coronavirus infections is perhaps premature.
Coronavirus Update: Lilly Begins Clinical Trial Of Antibody Therapy
Discovered at record-breaking speed by AbCellera, Lilly says the antibody candidate could progress into Phase II trials by June.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.